Choreo LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
17,625
+1,646
+10% +$19.7K ﹤0.01% 1457
2026
Q1
$95.7K Buy
+15,979
New +$120K ﹤0.01% 1542
2025
Q4
Sell
-14,486
Closed -$155K 1638
2025
Q3
$155K Buy
14,486
+848
+6% +$8.32K ﹤0.01% 1488
2025
Q2
$132K Sell
13,638
-10,267
-43% -$106K ﹤0.01% 1442
2025
Q1
$356K Buy
23,905
+2,917
+14% +$44.9K 0.01% 1012
2024
Q4
$308K Sell
20,988
-11,780
-36% -$192K ﹤0.01% 1172
2024
Q3
$617K Buy
32,768
+5,195
+19% +$108K 0.01% 798
2024
Q2
$561K Buy
+27,573
New +$548K 0.01% 764

Other funds holding OGN

Choreo LLC's OGN Position: Q2 2026 in Review

Choreo LLC increased its Organon & Co (OGN) stake by 10% in Q2 2026, buying an estimated $19.7K and bringing the position to 17,625 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Choreo LLC first reported a position in OGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $617K in Q3 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Choreo LLC held 17,625 shares of Organon & Co worth $239K as of Q2 2026.
  • Choreo LLC bought 1,646 Organon & Co shares in Q2 2026, an estimated $19.7K.
  • Organon & Co made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1457 holding.
  • Choreo LLC first reported a position in Organon & Co in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Organon & Co position peaked at $617K in Q3 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.